All In Biotech

Drug Trial Radar · NCT07369011

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

A Master Protocol for Phase 3 Randomized, Double-Blind, Placebo-Controlled Studies to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Moderate to Severe Obstructive Sleep Apnea, and Obesity or Overweight

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 800 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

800

Planned (sponsor's estimate)

Start

Feb 10, 2026

Primary completion

Mar 2028

Study completion Apr 2028

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Jan 27, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the studies is to evaluate the efficacy and safety of eloralintide in participants with moderate-to-severe obstructive sleep apnea and obesity or overweight. YDAO is a master protocol designed to support two independent studies: YSA1 and YSA2. Study YSA1 will include participants who are unable or unwilling to use Positive Airway Pressure (PAP) therapy and study YSA2 will include participants who are on PAP therapy for at least 3 months at time of screening and plan to continue PAP therapy during the study. Participants will be assigned to the Intervention-Specific Appendix (ISA) that reflects their current PAP usage. Participation in the study will last about 76 weeks.

Conditions

  • Sleep Apnea, Obstructive
  • Obesity
  • Overweight

Interventions

  • EloralintideDrug

    Administered SC

  • PlaceboDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change from Baseline in Body WeightTime frame: Baseline, Week 64
  2. Change from Baseline in Apnea-Hypopnea Index (AHI)Time frame: Baseline, Week 64

Locations

115 sites in 11 countries. Site status is shown where the registry gives one.

  • Cullman Clinical Trials

    Cullman, Alabama · Recruiting

  • Ark Clinical Research

    Long Beach, California · Recruiting

  • Collaborative Neuroscience Research, LLC

    Los Alamitos, California · Recruiting

  • Artemis Institute for Clinical Research

    Riverside, California · Recruiting

  • Care Access - Aurora

    Aurora, Colorado · Recruiting

  • Flourish Research - Miami, LLC

    Miami, Florida · Recruiting

  • PharmaDev Clinical Research Institute, LLC

    Miami, Florida · Recruiting

  • Emerald Coast Neurology - Airport Boulevard

    Pensacola, Florida · Recruiting

  • Teak Research Consults

    Lawrenceville, Georgia · Recruiting

  • EBGS Clinical Research Center

    Snellville, Georgia · Recruiting

  • Care Access - Shreveport 2

    Shreveport, Louisiana · Recruiting

  • Flourish Research - Bowie

    Bowie, Maryland · Recruiting

  • Revive Research Institute, Inc.

    Southfield, Michigan · Recruiting

  • Headlands Research-Twin Cities

    Maplewood, Minnesota · Recruiting

  • Clayton Sleep Institute - St. Louis - Tesson Ferry Road

    St Louis, Missouri · Recruiting

  • Palm Research Center Tenaya

    Las Vegas, Nevada · Recruiting

  • The Sleep Spot - Maimonides

    Albuquerque, New Mexico · Recruiting

  • Rochester Clinical Research - Buffalo

    Buffalo, New York · Recruiting

  • CTI Clinical Research Center

    Cincinnati, Ohio · Recruiting

  • Bogan Sleep Consultants

    Columbia, South Carolina · Recruiting

  • FutureSearch Trials of Neurology

    Austin, Texas · Recruiting

  • Sleep Therapy Research Center

    San Antonio, Texas · Recruiting

  • Consano Clinical Research, LLC

    Shavano Park, Texas · Recruiting

  • Nightingale Research

    Adelaide, Australia · Recruiting

  • Flinders University

    Bedford Park, Australia · Recruiting

  • Box Hill Hospital

    Box Hill, Australia · Recruiting

  • Core Research Group

    Brisbane, Australia · Recruiting

  • Austin Health - Repatriation Hospital

    Heidelberg West, Australia · Recruiting

  • CDH Research Institute Pty Ltd

    Maroochydore, Australia · Recruiting

  • Gold Coast University Hospital

    Southport, Australia · Recruiting

  • TrialsWest - Spearwood

    Spearwood, Australia · Recruiting

  • Instituto de Pesquisa clinica de Campinas

    Campinas, Brazil · Suspended

  • Centro de Pesquisa Clínica de Marília - CPCLIM

    Marília, Brazil · Suspended

  • Núcleo de Pesquisa Clínica do Rio Grande do Sul

    Porto Alegre, Brazil · Suspended

  • CEMER - Centro Médico do Recife

    Recife, Brazil · Suspended

  • Ruschel Medicina e Pesquisa Clínica

    Rio de Janeiro, Brazil · Suspended

  • Prognosis Pesquisa Clínica

    Santo André, Brazil · Suspended

  • CPHosp Medicina, Ensino e Pesquisa (CPQuali)

    São Paulo, Brazil · Suspended

  • BR Trials - Ensaios Clinicos e Consultoria

    São Paulo, Brazil · Suspended

  • CEPIC - Centro Paulista de Investigação Clínica

    São Paulo, Brazil · Suspended

Showing 40 of 115 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.